StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
China Resources Double-Crane Pharmaceutical Co.,Ltd.
Shanghai Stock Exchange:600062.SS
Sector
Location
Market Cap
USD 2.75 B
Share Price
USD 2.65
Avg Daily Volume
10,338,735
Change (1 day)
1.65%
Change (1 year)
10.50%
Change (YTD)
-2.37%
China Resources Double-Crane Pharmaceutical Co.,Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 249.97 M
China Resources Double-Crane Pharmaceutical Co.,Ltd. Operating Cash Flow is USD 249.97 M for the year ending December 31, 2024, a 8.83% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
China Resources Double-Crane Pharmaceutical Co.,Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 229.70 M, a 18.14% change year over year.
-
China Resources Double-Crane Pharmaceutical Co.,Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 194.42 M, a -7.87% change year over year.
-
China Resources Double-Crane Pharmaceutical Co.,Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 211.03 M, a 1.28% change year over year.
-
China Resources Double-Crane Pharmaceutical Co.,Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 208.38 M, a 0.78% change year over year.
Competitors
Eli Lilly and Company
USD 771.75
LLY
-27.59
-3.45%
AbbVie Inc.
USD 186.39
ABBV
-5.13
-2.68%
Roche Holding AG
USD 337.03
RO.SW
-6.82
-1.98%
AstraZeneca PLC
USD 140.43
AZN.L
-2.72
-1.90%
Merck & Co., Inc.
USD 81.52
MRK
-2.15
-2.57%
Amgen Inc.
USD 292.51
AMGN
-4.52
-1.52%
Pfizer Inc.
USD 24.61
PFE
-0.74
-2.92%
Gilead Sciences, Inc.
USD 109.06
GILD
-3.03
-2.70%
Sanofi
USD 95.94
SAN.PA
-1.50
-1.54%
Bristol-Myers Squibb Company
USD 46.43
BMY
-0.91
-1.92%
GSK plc
USD 18.76
GSK.L
-0.36
-1.89%
Chugai Pharmaceutical Co., Ltd.
USD 45.53
4519.T
-0.47
-1.02%
Regeneron Pharmaceuticals, Inc.
USD 547.96
REGN
-22.63
-3.97%
Cencora, Inc.
USD 294.65
COR
-2.41
-0.81%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.01
600276.SS
+0.03
0.41%
Takeda Pharmaceutical Company Limited
USD 29.48
4502.T
-0.38
-1.26%
Haleon plc
USD 4.86
HLN.L
-0.07
-1.38%
Daiichi Sankyo Company, Limited
USD 23.31
4568.T
+0.41
1.79%
Ucb S.A.
USD 198.03
UCB.BR
-3.24
-1.61%
BeOne Medicines Ltd.
USD 269.70
ONC
+17.56
6.96%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 771.75
LLY
-27.59
-3.45%
AbbVie Inc.
USD 186.39
ABBV
-5.13
-2.68%
Roche Holding AG
USD 337.03
RO.SW
-6.82
-1.98%
AstraZeneca PLC
USD 140.43
AZN.L
-2.72
-1.90%
Merck & Co., Inc.
USD 81.52
MRK
-2.15
-2.57%
Amgen Inc.
USD 292.51
AMGN
-4.52
-1.52%
Pfizer Inc.
USD 24.61
PFE
-0.74
-2.92%
Gilead Sciences, Inc.
USD 109.06
GILD
-3.03
-2.70%
Sanofi
USD 95.94
SAN.PA
-1.50
-1.54%
Bristol-Myers Squibb Company
USD 46.43
BMY
-0.91
-1.92%
GSK plc
USD 18.76
GSK.L
-0.36
-1.89%
Chugai Pharmaceutical Co., Ltd.
USD 45.53
4519.T
-0.47
-1.02%
Regeneron Pharmaceuticals, Inc.
USD 547.96
REGN
-22.63
-3.97%
Cencora, Inc.
USD 294.65
COR
-2.41
-0.81%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.01
600276.SS
+0.03
0.41%
Takeda Pharmaceutical Company Limited
USD 29.48
4502.T
-0.38
-1.26%
Haleon plc
USD 4.86
HLN.L
-0.07
-1.38%
Daiichi Sankyo Company, Limited
USD 23.31
4568.T
+0.41
1.79%
Ucb S.A.
USD 198.03
UCB.BR
-3.24
-1.61%
BeOne Medicines Ltd.
USD 269.70
ONC
+17.56
6.96%